Gbadegesin Bosede Ikeolu 4
Research Summary
AI-generated summary
Eastman Chemical (EMN) SVP Gbadegesin Receives Stock Awards
What Happened
- Gbadegesin Bosede Ikeolu, Senior Vice President, Chief Legal Officer & Corporate Secretary of Eastman Chemical (EMN), received equity awards on February 24, 2026: 33,223 option-based awards and 4,571 restricted stock units (RSUs). Both items are reported as awards (Form 4 transaction code A) and are recorded at $0.00 per share in the filing (derivative awards — no cash purchase).
Key Details
- Transaction date: 2026-02-24; Form 4 filed 2026-02-26 (timely — within the required filing window).
- Grants: 33,223 option awards (derivative) and 4,571 RSUs (derivative); both reported at $0.00.
- Shares owned after transaction: Not disclosed in the excerpt of the filing provided.
- Footnotes:
- F1: Options vest in three equal installments — one-third on Feb 24 of 2027, 2028, and 2029.
- F2: Each RSU equals a contingent right to one share of common stock.
- F3: RSUs vest and will be paid out in unrestricted shares on the third anniversary (Feb 24, 2029), subject to continued employment.
- Transaction code A = award/grant; these are not open-market purchases or sales.
Context
- These are standard long-term incentive awards common for executives: the options give the right to purchase shares in the future (vesting schedule above) and the RSUs convert to shares if vesting conditions are met. Because they are grants (not purchases or sales), they do not directly signal immediate buying or selling activity by the insider.